Lipocine Inc. Quarterly Operating Income (Loss) in USD from Q1 2012 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Lipocine Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2012 to Q3 2024.
  • Lipocine Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$2.63M, a 62.7% increase year-over-year.
  • Lipocine Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$5.29M, a 70.4% increase year-over-year.
  • Lipocine Inc. annual Operating Income (Loss) for 2023 was -$17.9M, a 48% decline from 2022.
  • Lipocine Inc. annual Operating Income (Loss) for 2022 was -$12.1M, a 485% decline from 2021.
  • Lipocine Inc. annual Operating Income (Loss) for 2021 was $3.15M.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$5.29M -$2.63M +$4.41M +62.7% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 -$9.71M -$3.29M +$663K +16.8% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 -$10.4M $3.22M +$7.56M Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 -$17.9M -$2.59M -$32.5K -1.27% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-07
Q3 2023 -$17.9M -$7.04M -$4.14M -143% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 -$13.8M -$3.96M -$428K -12.1% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 -$13.3M -$4.34M -$1.21M -38.5% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 -$12.1M -$2.56M -$15.3M -120% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-07
Q3 2022 $3.23M -$2.9M +$634K +18% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 $2.59M -$3.53M -$537K -18% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 $3.13M -$3.13M -$17.1K -0.55% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 $3.15M $12.8M +$17.6M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-10
Q3 2021 -$14.4M -$3.53M +$841K +19.2% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 -$15.3M -$2.99M +$1.23M +29.2% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 -$16.5M -$3.11M +$1.48M +32.3% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q4 2020 -$18M -$4.8M -$1.35M -39.3% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-09
Q3 2020 -$16.6M -$4.38M -$1.4M -47% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 -$15.2M -$4.22M -$872K -26% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 -$14.4M -$4.6M -$1.47M -47.1% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 -$12.9M -$3.45M -$277K -8.73% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-11
Q3 2019 -$12.6M -$2.98M -$623K -26.5% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-10
Q2 2019 -$12M -$3.35M -$186K -5.88% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 -$11.8M -$3.13M -$489K -18.5% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 -$11.3M -$3.17M +$2.23M +41.3% Oct 1, 2018 Dec 31, 2018 10-K 2019-03-06
Q3 2018 -$13.6M -$2.35M +$2.41M +50.6% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 -$16M -$3.16M +$2.98M +48.5% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-07
Q1 2018 -$18.9M -$2.64M +$2.27M +46.3% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-08
Q4 2017 -$21.2M -$5.4M -$2.39M -79.2% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-06
Q3 2017 -$18.8M -$4.77M -$1.48M -45% Jul 1, 2017 Sep 30, 2017 10-K 2019-03-06
Q2 2017 -$17.4M -$6.14M -$325K -5.6% Apr 1, 2017 Jun 30, 2017 10-K 2019-03-06
Q1 2017 -$17M -$4.91M +$2.16M +30.6% Jan 1, 2017 Mar 31, 2017 10-K 2019-03-06
Q4 2016 -$19.2M -$3.02M +$1.68M +35.8% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-12
Q3 2016 -$20.9M -$3.29M +$3.15M +48.9% Jul 1, 2016 Sep 30, 2016 10-K 2018-03-12
Q2 2016 -$24M -$5.82M -$1.54M -35.9% Apr 1, 2016 Jun 30, 2016 10-K 2018-03-12
Q1 2016 -$22.5M -$7.07M -$4.1M -138% Jan 1, 2016 Mar 31, 2016 10-K 2018-03-12
Q4 2015 -$18.4M -$4.7M -$636K -15.7% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-06
Q3 2015 -$17.7M -$6.43M -$2.32M -56.2% Jul 1, 2015 Sep 30, 2015 10-K 2017-03-06
Q2 2015 -$15.4M -$4.28M +$2.73M +39% Apr 1, 2015 Jun 30, 2015 10-K 2017-03-06
Q1 2015 -$18.2M -$2.97M +$2.32M +43.8% Jan 1, 2015 Mar 31, 2015 10-K 2017-03-06
Q4 2014 -$20.5M -$4.06M +$352K +7.98% Oct 1, 2014 Dec 31, 2014 10-K 2017-03-06
Q3 2014 -$20.8M -$4.12M -$573K -16.1% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-12
Q2 2014 -$20.3M -$7.01M -$5.64M -410% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-11
Q1 2014 -$14.6M -$5.29M -$3.94M -291% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-07
Q4 2013 -$10.7M -$4.41M Oct 1, 2013 Dec 31, 2013 10-K 2015-03-11
Q3 2013 -$3.55M -$2.53M -249% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-10
Q2 2013 -$1.37M Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-13
Q1 2013 -$1.35M +$3.46M +71.9% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-13
Q3 2012 -$1.02M Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-13
Q1 2012 -$4.81M Jan 1, 2012 Mar 31, 2012 10-Q 2012-05-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.